Objectives: Cognitive decline related to neurocysticercosis (NC) remains poorly characterized and underdiagnosed. In a cross-sectional study with a prospective phase, we evaluated cognitive decline in patients with strictly calcified form (C-NC), the epidemiologically largest subgroup of NC, and investigated whether there is a spectrum of cognitive abnormalities in the disease.
Neurocysticercosis (NC) is a prevalent chronic parasitic disease caused by invasion of the CNS by
Taenia solium larvae. 1 The disease is still endemic in Latin America, Africa, and Asia, where it develops its complete life cycle owing to poor sanitary conditions. 2 NC is also emerging in developed countries, due to human migration, and has been recently reported to occur by local transmission. 3 NC-related cognitive impairment is one of the most frequent manifestations of the disease along with symptomatic seizures, epilepsy, focal neurologic deficits, and headache secondary to intracranial hypertension. 4, 5 Recently, we reported that patients with cystic lesions were found to present significant cognitive impairment, including dementia in some cases. 6 Despite the importance of these data, patients with cystic lesions represent only a small part of the population of NC individuals. 7 The largest subgroup, representing about 70% of cases, is composed of patients with calcified lesions, which is the final common pathway of the disease and is not responsive to antiparasitic treatment. 7 The occurrence of cognitive decline and dementia in patients with calcified NC (C-NC) would have a major negative socioeconomic impact in endemic areas and would provide us insight on the mechanisms of NC-related cognitive dysfunction.
We conducted a thorough cognitive and functional evaluation in patients with C-NC and compared them with age-and educationmatched healthy controls (HC) and with matched patients presenting active NC (A-NC). Patients fulfilling criteria for dementia were reassessed after 24 months. METHODS Participants. All participants were evaluated by 2 blinded experienced neurologists (C.L.R. and D.C.A.). All individuals underwent neurologic examination, alcohol abuse screening through the CAGE and Alcohol Use Disorders Identification Test questionnaires, 8, 9 and appropriate blood tests (complete blood cell count, electrolytes, thyroid function tests, vitamin B12 levels, syphilis, and HIV immunology). 10 Individuals from the HC groups presenting altered blood tests, current alcohol abuse, or depression were excluded from the study. The presence of current high blood cholesterol, hypertension, diabetes mellitus, thyroid dysfunction, depressive symptoms, stroke, and history of head trauma were assessed in all participants.
All individuals fulfilled definitive criteria for NC at some point of disease course, according to current definitions. 11 Patients with definite disease and presenting at least 1 calcified NC lesion on a recent CT of the skull were included in the C-NC group. They had only strict calcified lesions at the moment of the cognitive evaluation. Patients with at least 1 intact cystic lesion with scolex (also called a vesicular lesion) on a recent MRI were included in the active group of NC (A-NC).
Patients fulfilling all the inclusion criteria from the C-NC and A-NC groups were screened for depression (DSM-IV criteria 12 ). Depressed patients with NC (both C and A groups) were treated with fluoxetine and were only evaluated after being asymptomatic for at least 2 months. Nondepressed patients with C-NC or A-NC underwent cognitive assessment only if 1) they had been seizure-free for at least 2 weeks preceding consultation; 2) they had been on a fixed dose of AED treatment during the last 30 days before evaluation; 3) they presented no clinical signs of AED intoxication (blood levels of AEDs were determined in cases of suspected intoxication and cognitive evaluation was only performed if they were within normal limits); and 4) they presented no signs of delirium on examination, based on the Delirium Rating Scale. 13 Patients not fulfilling these criteria had their cognitive evaluation postponed for 2 months and had a new MRI (A-NC group) performed to assess the presence of degenerating cysts. Patients with transitional lesions on MRI (i.e., degenerating cysts) or delirium symptoms had their cognitive evaluation withdrawn from the analysis.
Standard protocol approvals, registrations, and patient consents. Approval was obtained from the institutional review board of the participating institution (Hospital das Clínicas, University of São Paulo) and written informed consent was obtained from all study participants.
Recruitment and matching strategy. The C-NC patients were consecutively recruited from January 2006 to November 2009 from the neuroinfectious diseases outpatient clinic of the "Hospital das Clínicas" from the University of São Paulo School of Medicine. Based on previous studies 14, 15 we considered that 40 patients in the calcified phase of NC would be enough to test our hypothesis. Matching was performed in blocks of 10 patients: for every 10 patients with C-NC included, age and level of education were ranked (age: 5-year, and level of education: 4-year intervals), and this information was used to recruit the next block of individuals from the HC and A-NC groups.
Patients with C-NC. Forty-four consecutive patients younger than 60 years presenting in the calcified phase of NC were included in the study. These patients initially met criteria for definite NC on the initial evaluation but developed exclusively calcified lesions during follow-up. CT was also used to assess disease burden, i.e., lesion number, general localization (right/ left side, cortical/subcortical), according to an optimized protocol. 16 All C-NC patients were submitted to MRI to exclude other causes of epilepsy (such as hippocampal sclerosis). Four patients with C-NC did not undergo cognitive evaluation because of refractory depression (n ϭ 2), chronic psychotic disorder (n ϭ 1), or postoperative frontal gliosis (n ϭ 1). Depression was present initially in 12 patients (27.2%) with C-NC and was successfully treated in 10 (83.3%) of them. Thus, 40 patients in NC calcified phase underwent cognitive and functional evaluation.
Comparison groups. Forty patients presenting with A-NC
(i.e., at least 1 cystic lesion with scolex on MRI) were included in the study and underwent cognitive and functional evaluation.
Forty HC fulfilled the inclusion criteria and underwent cognitive examination, mostly members of the hospital staff or patient relatives, with no personal history of epilepsy, chronic intestinal infections, or neurologic disease. They all underwent a CT scan.
Cognitive and functional evaluation. All participants underwent cognitive and functional evaluations, including Mini-Mental State Examination, 17, 18 digit-span forward (DSF) and backward (DSB), 19 clock-drawing test (CDT), 10-word list recall, Constructive Praxis Test and Category Fluency Test (CFT), Boston Naming Test (BNT), and the Trail-Making Test (TMT-A and -B) from the Comprehensive Battery of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD), 20,21 the Brief Cognitive Screening Battery (BCSB), 22 and the Stroop Color-Interference Test (SCIT). 23 Functional status was assessed by the Pfeffer Functional Activities Questionnaire (PFAQ) scored by a close relative. PFAQ scores Ͼ5 were considered indicative of functional impairment. 24 Dementia was diagnosed according to DSM-IV criteria, 12 with memory impairment defined by scores below the 95% confidence interval (CI) of HC performance in the delayed recall sections of both the CERAD and the BCSB, in conjunction with altered scores in at least 1 additional cognitive test and functional impairment. Cognitive impairment-no dementia (CIND) was diagnosed in patients fulfilling these same criteria, except for functional impairment. The patients with dementia were reassessed after 24 months using the same protocol.
Statistical analysis. Group data without normal distribution
under the Shapiro-Wilk test were compared using the nonparametric Kruskal-Wallis test followed by Mann-Whitney test within groups, whenever indicated. Correlation analyses were performed using the Spearman correlation test. Multiple regression analyses were performed to study independent variables potentially related or not to cognitive performance. Cognitive scores for each patient with C-NC were compared with performance of controls. Scores below the 95% CI (significance level: ␣ ϭ 5%) were considered abnormal, except for timed ones (TMT-A, TMT-B, and SCIT), where values higher than the 95% CI were considered as altered. Data obtained from cognitive tests were grouped by cognitive domains and expressed as z scores. Categorical variables were compared by Fisher exact test. The p values shown below are from 2-tailed tests.
RESULTS
Participants from the 3 groups (C-NC, A-NC, and HC) had similar age (37.6 Ϯ 11.3; 39.2 Ϯ 10.5; 40.3 Ϯ 12.2 years; p ϭ 0.600) and educational level (7.0 Ϯ 3.6; 6.2 Ϯ 4.0; 7.2 Ϯ 3.7 years; p ϭ 0.395). The C-NC group presented with significantly lower monthly seizure frequency than the A-NC group (0.2 Ϯ 0.3 and 5.1 Ϯ 2.3, respectively; p Ͻ 0.001). The majority (90%) of patients in both A-NC and C-NC groups presented with focal seizures as the main or unique seizure type. AED regimen was not significantly different between the groups (table 1). Most patients from C-NC and A-NC groups had at least 1 epileptic seizure in their clinical history and 60% of them developed epilepsy during follow-up. Thirty-one individuals from the A-NC group also presented other lesions types con-comitantly on the first image study, such as transitional or calcified lesions.
Cognitive evaluation. Between-group analysis. There were no statistically significant differences between performance of C-NC and HC groups in any cognitive tests and subtests assessed (p Ͼ 0.05). However, the C-NC group showed better cognitive performance than the A-NC group in tests assessing naming (BNT), verbal fluency (CFT), and nonverbal memory (BCSB and delayed recall of constructive praxis of the CERAD) (p Ͻ 0.001, p ϭ 0.006, p ϭ 0.027, p ϭ 0.001, respectively) (table 2 and appendix e-1 on the Neurology ® Web site at www.neurology.org).
Within-group analysis. All patients with C-NC showed lower scores on at least one cognitive test compared with the HC group. Patients with C-NC presented an average of 9.4 Ϯ 3.1 altered test scores out of the 30 in our battery when compared to HC, while A-NC patients presented a significantly higher number of altered tests (11.6 Ϯ 3.9, p ϭ 0.012) (table 3) . Memory, attention, executive functions, language, and visuospatial skills were altered in more than 50% of C-NC patients (table 4 and appendix e-2).
No patient in the C-NC group showed functional impairment, thus no patient fulfilled the diagnostic criteria for dementia. Ten patients (25%) presented CIND. The A-NC group had 5 patients with dementia (12.5% of the sample) and 11 patients with CIND (27.5% of the sample) (table 3). The A-NC patients with and without dementia did not differ significantly in relation to age (44.4 Ϯ 10.0 and 38.5 Ϯ 5.4 years; p ϭ 0.26), education (4.2 Ϯ 3.9 and 6.2 Ϯ 3.6 years; p ϭ 0.23), presence of successfully treated depression (20% and 28%; p ϭ 0.97), and monthly seizure frequency (6.2 Ϯ 1.7 and 5.3 Ϯ 2.5; p ϭ 0.58, respectively).
We found no correlation between cognitive scores and age, education, monthly seizure frequency, and number of AEDs for each patient in the C-NC and A-NC groups, either when the groups were analyzed separately or pooled (total of 80 patients).
The C-NC group had significantly fewer lesions than the A-NC group (table 3) . C-NC patients with Table 1 Main sociodemographic data, seizure frequency, and antiepileptic drug regimen of the participants We found no correlation between cognitive scores and the number and localization of lesions for each patient in the C-NC and A-NC groups, either when they were analyzed separately or pooled (total of 80 patients).
In multiple linear regression analysis, no correlation was found between cognitive scores and age, education, monthly seizure frequency, and number of lesions simultaneously for each patient in C-NC and A-NC groups, either when they were analyzed separately or pooled (total of 80 patients) (R 2 ϭ 13.4% and p Ͼ 0.05).
Long-term follow-up. No C-NC patients developed dementia on follow-up of 24 months. Three out of the 5 A-NC patients with dementia on the first assessment still fulfilled these diagnostic criteria in the re-evaluation performed 24 months later, still presenting cystic lesions with scolex (active disease) on the follow-up MRI. One patient died due to unrelated causes and 1 patient no longer fulfilled criteria for either dementia or CIND. In the second MRI/CT scan, this patient presented exclusively with calcified lesions. DISCUSSION We performed a controlled study to compare the cognitive profile of different phases of NC. NC irrespective of its phase (calcified or active) was associated with significant cognitive decline when compared with age-and education-matched healthy controls. Interestingly, dementia was present exclusively in patients with active disease, although CIND was present in both calcified and active groups. Our findings show that patients with NC exhibit a wide range of cognitive decline, going from impairment in at least one cognitive test through an amnestic pattern without functional impairment in both C-and A-NC, and finally reaching full-blown dementia in some individuals with A-NC. All cognitive domains could be affected. Cognitive performance of these patients, albeit below normal, was superior to those of patients with A-NC.
Since cystic lesions go through different evolutionary stages (i.e., cystic, transitional, and calcified), irrespective of the presence of specific treatment, 25 one single patient may present lesions in different phases of their natural history. One approach to overcome this challenge is to assess more homogenous subgroups of patients. We decided to evaluate the extremes of the continuum: patients with active lesions and those with exclusive chronic calcified lesions (C-NC).
Psychiatric manifestations related to NC are well described in previous studies and have been reviewed elsewhere. 26, 27 The high frequency of initially depressed patients in our sample was similar to the works previously mentioned. 26, 27 Since the presence of depression or delirium is known to influence the results of cognitive tests, we only evaluated nondepressed patients who were not under delirium in order to overcome this source of bias. 6 In the longitudinal phase of a landmark study, 15 the authors showed that most patients with active NC lesions treated with a regular pharmacologic regimen experienced cognitive improvement, no longer fulfilling the diagnosis of dementia in some cases. Despite the lack of a control group, these findings have a major impact on the decision of when to start antiparasitic treatment in NC patients, especially in those with cognitive decline or dementia. However, in some clinical scenarios, especially in rural areas where no public education programs exist and patients are exposed to reinfection, patients may present with multiple lesions, most often in different phases of evolution. The present study was performed in a tertiary university hospital that receives patients from general practitioners and secondary hospitals. The vast majority of these patients had more than 5 active lesions when they were first assessed. Based on our clinical experience and on previous reports, we did not offer antiparasitic treatment to patients presenting multiple brain lesions, due to the high risk of encephalitis and uncontrolled seizures due to the synchronous degenerations of all the lesions. 28, 29 Instead, we use AED when indicated and steroids to control for excessive vasogenic edema. If on one hand we ended up with a group of patients with a relatively more severe form of the disease, on the other hand, we had the unique possibility to study the clinical presentation of the disease in antiparasitic-naive patients.
Three out of 5 patients who initially presented with dementia remained so after 2 years. Interestingly, the only patient who no longer fulfilled criteria for dementia during follow-up initially had active vesicular lesions that evolved to exclusively calcified forms after 2 years. We hypothesize that major cognitive dysfunction may occur as long as active cystic lesions are present in these patients. As the lesions become calcified, patients would move to a less severe form of cognitive impairment. This hypothesis needs to be confirmed by further prospective studies. However, it opens the debate on how to deal with patients presenting with cognitive decline and multiple active lesions who cannot tolerate antiparasitic therapy.
In our 80 patients, cognitive scores did not correlate with the number of lesions or with their localization on CT or MRI. Two previous studies also found no correlation between neuroimaging and neuropsychiatric and cognitive findings. 6, 14 Despite the high number of lesions of our patients, this lack of correlation emphasizes that cognitive impairment in NC seems not to be determined by disease burden measured by lesion number alone, but rather the synergistic interaction among number, localization, different evolutionary phases, and the local production of varying degrees of inflammation and brain edema. 30 These processes seem to be attenuated in the calcified phase, leading to more subtle cognitive dysfunction.
The results of our controlled study show that NC, independently of its phase, leads to a spectrum of cognitive abnormalities, ranging from impairment in a single domain to CIND and, occasionally, to dementia. Major cognitive impairment is more conspicuous during the active vesicular phase, less prominent in the calcified stages, and seems to persist while active lesions are present.
